Atlas Trials

Stage IVA Nasopharyngeal Carcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IVA Nasopharyngeal Carcinoma

RecordFirmDate
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864)Alain Algazi2020-12-01
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer (NCT03049358)Stanford University2016-12-01
Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA (NCT02135042)NRG Oncology2014-04-21

Track Stage IVA Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.